Valneva : in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Kort samengevat
Saint-Herblain , January 12, 2021 – Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it is in advanced...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij MarketScreener.
Lees het volledige bericht ↗